Your browser doesn't support javascript.
loading
Propofol suppresses the His-ventricular conduction in paediatric patients.
Matsushima, Mayuka; Kimura, Seishi; Kitaura, Atsuhiro; Hamasaki, Shinichi; Iwamoto, Tatsushige; Mino, Takashi; Masui, Kenichi; Nakao, Shinichi.
Afiliación
  • Matsushima M; Department of Anesthesiology, Faculty of Medicine, Kindai University, OsakaSayama, Osaka, Japan.
  • Kimura S; Department of Anesthesiology, Faculty of Medicine, Kindai University, OsakaSayama, Osaka, Japan.
  • Kitaura A; Department of Anesthesiology, Faculty of Medicine, Kindai University, OsakaSayama, Osaka, Japan.
  • Hamasaki S; Department of Anesthesiology, Faculty of Medicine, Kindai University, OsakaSayama, Osaka, Japan.
  • Iwamoto T; Department of Anesthesiology, Faculty of Medicine, Kindai University, OsakaSayama, Osaka, Japan.
  • Mino T; Department of Anesthesiology, Faculty of Medicine, Kindai University, OsakaSayama, Osaka, Japan.
  • Masui K; Department of Anesthesiology, Showa University School of Medicine, Shinagawa, Tokyo, Japan.
  • Nakao S; Department of Anesthesiology, Faculty of Medicine, Kindai University, OsakaSayama, Osaka, Japan.
J Clin Pharm Ther ; 46(2): 433-439, 2021 Apr.
Article en En | MEDLINE | ID: mdl-33098128
WHAT IS KNOWN AND OBJECTIVE: Propofol is the most commonly used intravenous anaesthetic worldwide and is considered to be safe for all ages. However, there have been some reports that propofol induces severe atrioventricular (AV) blocks in humans and some studies demonstrated that propofol suppressed the cardiac conduction system in animals. A precise mechanism by which the block is induced has not been elucidated yet in humans. The objective of this study was to investigate the effects of propofol on the cardiac conduction system and the cardiac autonomic nervous balance in children. METHODS: We enrolled 23 paediatric patients (age: 6-15 years; males: 16, females: 7) who were scheduled to undergo radiofrequency catheter ablation (RFCA) under general anaesthesia. Anaesthesia was induced with 2 mg/kg propofol and 0.5 µg/kg/min remifentanil, and tracheal intubation was performed with the aid of 1 mg/kg rocuronium. Anaesthesia was maintained with 5-7 mg/kg/h propofol and 0.2 µg/kg/min remifentanil during the RFCA. After the completion of the RFCA, anaesthesia was further maintained with 5 mg/kg/h propofol and 0.2 µg/kg/min remifentanil for at least 10 min (LC: low propofol concentration state), followed by the injection of 2 mg/kg propofol and the infusion of 10 mg/kg/h propofol for 10 min (HC: high propofol concentration state). The sinus node recovery time (SNRT), sinoatrial conduction time (SACT), atrial-His (AH) interval and the His-ventricular (HV) interval were measured at the end of both the LC and HC. Cardiac autonomic regulation was simultaneously assessed based on heart rate variability. RESULTS AND DISCUSSION: Propofol significantly suppressed intrinsic cardiac HV conduction, but did not affect the SNRT, SACT or the AH interval. As HV blocks, which occur below the His bundle, are often life-threatening, the HV conduction delay may be a cause of severe AV blocks induced by propofol. Propofol directly suppressed parasympathetic nerve activity, and sympathetic nerve activity was also suppressed. WHAT IS NEW AND CONCLUSION: These results indicate that propofol suppresses the HV conduction and might help to elucidate the mechanism by which propofol causes lethal AV blocks.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Propofol / Anestésicos Intravenosos / Sistema de Conducción Cardíaco / Frecuencia Cardíaca Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Propofol / Anestésicos Intravenosos / Sistema de Conducción Cardíaco / Frecuencia Cardíaca Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Japón